EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Teva and Samsung Bioepis have launched Epysqli, a cost-saving Soliris biosimilar, offering a 30% discount and new hope for ...

Bkemv is being offered at 10% off Soliris, and Epysqli is offered at 30% below Soliris. Both biosimilars treat several of the ...

EXTON, PA, March 18, 2025 (GLOBE NEWSWIRE) -- Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare and debilitating blood disorder that affects approximately 8,000 to 10,000 people in North America ...

today reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart in paroxysmal nocturnal hemoglobinuria (PNH). Zaltenibart ...

The company is dropping its former lead molecule in favor of another antibody, RLYB116, which is being developed for a ...

EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...

KORU Medical Systems, Inc.’s KRMD share price has dipped by 9.22%, which has investors questioning if this is right time to ...

MASP-3 inhibitors are thought to have preventive or therapeutic effects across a broad range of diseases including paroxysmal nocturnal hemoglobinuria (PNH), hemolytic uremic syndrome (HUS ...

“Individuals living with rare diseases, including paroxysmal nocturnal hemoglobinuria ... “Life-threatening diseases such as PNH, aHUS and gMG, if left untreated, can lead to kidney disease ...